Interneuronal transfer of pathological α-synuclein species is thought to play an important role in the progressive advancement of Lewy pathology and increasing severity of clinical manifestations in Parkinson’s and other diseases commonly referred to as synucleinopathies. Here, SNCA is linked to Parkinson disease.